News
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
Event details are available on the Immix website in the Presentation & Events section at https://immixbio.com/investors/#investor-presentation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results